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G-quadruplex ligands exhibit diﬀerential G-tetrad
selectivity†
D. D. Le,a M. Di Antonio,ab L. K. M. Chana and S. Balasubramanian*abc
A rapid and simple equilibrium-binding assay mediated by ligand-
induced fluorescence quenching of fluorophore-labelled G-quadruplex
(G4) structures enabled quantitative interrogation of mutually exclusive
ligand binding interactions at opposed G-tetrads. This technique
revealed that the ligands TmPyP4, PhenDC3, and PDS have diﬀerential
chemotype-specific binding preferences for individual G-tetrads of a
model genomic G4 structure.
While the primary sequences of DNA and RNA encode the
fundamental information necessary for cellular function, it is
the secondary structure adopted by these molecules that, in
part, dynamically regulates their activity.1 One such regulatory
structure is the guanine quadruplex, which has been shown to
influence core cellular processes such as replication, transcription
and translation.1,2 Structures of this type arise in G-rich sequences
where guanines assemble intomulti-layered tetrad planes (G-tetrads),
stabilized by Hoogsteen hydrogen-bonding and p–p stacking (Fig. 1).
Importantly, G4 structures may be associated with DNA instability
and cancer progression; thus, pharmacological targeting of G4s has
considerable potential for probing cancer biology and modulating
cancer phenotypes.3
The disparate features of G4 architecture, revealed by structural
studies, present unique topologies that determine the potential
modes of ligand binding: tetrad-stacking, groove-binding, and
loop-binding.4 Furthermore, individual G-tetrad ends of a given
G4 structure are chemically distinct environments that influence
small molecule interactions. Given this structural heterogeneity,
the development of selective G4 ligands has, to some extent, been
constrained by the resolution of current techniques to quantitate
equilibrium ligand binding at specific sites within G-quadruplexes.
Because the most ubiquitous G4 ligand chemotypes are based on
planar aromatic scaﬀolds, which interact primarily via p–p stacking
to G-tetrad ends, these compounds are predicted to access both
G-tetrads of a given G4 structure.5 However, widely adopted
methods to characterize G4 ligand interactions, such as G4 thermal
shift (G4 FRET-melting) and G4 fluorescent intercalator displace-
ment (G4-FID)—while rapid and simple to implement—can not
quantitate the equilibrium constants of individual G-tetrad binding
sites.6 To better probe the binding characteristics of G-quadruplexes
and their small molecule ligands, described here is a fluorescence-
based binding assay that rapidly, simply, and accurately measures
apparent equilibrium dissociation constants (K appD ) at defined sites
on G4 structures.
Building upon the utility of reported fluorescence quench
assays, the present work describes diﬀerentially fluorophore-
labelled G4-forming oligonucleotides (oligos), which exhibit
quenching mediated by proximal ligand binding at individual
G-tetrads (Fig. 1).7 This ligand-induced phenomenon was devel-
oped into a general G4 binding assay to enable measurement of
K appD for the established ligands TmPyP4, PhenDC3, and pyridostatin
(PDS) with several G4 structures.8 The assay platform was based
on initial observations that the G4-specific ligand PDS causes
dose-dependent loss of fluorescence emission on a 50-Cy5
labelled DNA oligo derived from the human telomeric repeat
sequence (50Cy5_hTelo) (Fig. 2A). The fluorescence quenching
Fig. 1 Tetrad-specific fluorescence quench equilibrium dissociation
binding assay for G-quadruplex ligands.
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phenomenon was shown to require a folded G4 structural context,
as the ligand-induced eﬀect was abrogated by nuclease digestion
and incomplete G-quadruplex folding in Li+ conditions (Fig. 2B;
Fig. S1, S2A and B, ESI†).9 Importantly, quenching was annulled by
competition with an unlabelled hTelo oligo, indicating that PDS
interacts specifically and reversibly with the labelled G4 struc-
ture to suppress fluorescence emission; whereas, competition
with a non-G4 mutant oligo did not reverse fluorescence
quenching (Fig. 2C). The competition results corroborate direct
quenching measurements, despite fluorophore-induced struc-
tural polymorphism common to hTelo constructs (Fig. 2B and
C and Fig. S2C, ESI†). Taken together, these data support a
proximal quenchingmechanism whereby ligands bind to structured
G4 elements in the vicinity of an excited-state fluorophore to induce
non-radiative dissipation. Thus, the extent of fluorescence quench-
ing is indicative of ligand binding.
To cross-validate the present assay results with previously
reported equilibrium dissociation constants, saturation binding
analysis was performed with the widely used G4 ligand TmPyP4
on several described G4 structures: 50-untranslated region (50UTR)
sequence of the NRAS proto-oncogene RNA transcript, c-Myc and
c-kit proto-oncogene promoters, and the human telomeric repeat
sequence (Table S2 and Fig. S3, ESI†).7c,10 Initially, comparisons of
measured values to reported equilibrium constants were compli-
cated by claims of multiple binding events (Table S2, ESI†).
Instances of two discrete binding transitions were described: a
high-aﬃnity event and one of low-aﬃnity. It was reasoned that the
transitions represent individual TmPyP4 binding events at G-tetrad
ends of a G4 structure with unique local topologies that cause
disparate binding equilibria. Therefore, to probe ligand binding at
either end of a G4 structure, diﬀerentially Cy5 end-labelled oligos
were used to measure 50-tetrad versus 30-tetrad quenching caused
by TmPyP4 interaction (Fig. 3A). Analysis of the hTelo sequence
revealed K appD = 1.9  0.2 mM and K appD = 0.15  0.01 mM for the
50Cy5_hTelo and 30Cy5_hTelo constructs, respectively (Fig. S3D,
ESI†). These measurements are consistent with reported dissocia-
tion equilibria determined by isothermal titration calorimetry
describing multiple binding events for TmPyP4 binding to hTelo:
2.0  0.2 mM and 0.25  0.3 mM (Table S2 and Fig. S4, ESI†).11
Similarly, high-aﬃnity and low-aﬃnity apparent binding constants
were observed for TmPyP4 with both cKit1 and cMyc structures, in
accordance with literature values (Fig. 3B, Fig. S3 and S4, ESI†).
Corroborating these observations are structural studies that have
suggested intrinsic ligand binding preferences for a particular
G-tetrad.12 For example, NMR spectroscopic analysis of the c-Myc
G-quadruplex in complex with TmPyP4 indicates preferential bind-
ing to the 50-end surface.12 Importantly, measured tetrad-specific
equilibrium dissociation results, enabled by the fluorescence
quench assay, are consistent with the proposed binding model:
50Cy5_cMyc K appD = 0.015  0.003 mM (high-aﬃnity) and
30Cy5_cMyc K appD = 0.31  0.02 mM (low-aﬃnity) (Fig. S3B and C,
ESI†). Taken together, the attribution of G-tetrad selectivity to
reported TmPyP4 binding equilibria builds upon a general struc-
tural rationale for the observations of dual binding events.
To better understand the binding preferences of common
G4 ligands, the present assay was used to quantitate G-tetrad
selectivity of TmPyP4, PhenDC3, and PDS toward the model G4
structure cKit1. Analysis of diﬀerentially Cy5 end-labelled cKit1
revealed that TmPyP4 exhibits an approximate 8-fold selectivity
for the 30-end tetrad (Fig. 3). In contrast, PhenDC3 displayed
the reverse selectivity trend, demonstrating 46-fold tighter
50-tetrad binding (Fig. 3). These results highlight the diﬀerences
in chemical environment between G-tetrads of a G4 structure that
determine ligand-specific binding preferences. Unlike TmPyP4 and
PhenDC3, the ligand PDS exhibited nearly equivalent binding
aﬃnity toward both G-tetrads of the cKit1 structure (Fig. S5, ESI†).
Quantitation of ligand equilibrium dissociation constants revealed
the inherent binding preferences of each chemotype toward the
Fig. 2 PDS binding to human telomeric DNA G4. (A) Dose-responsive
Cy5 emission spectrum (inset: absolute change in RFU), (B) PDS-induced
saturation of fluorescence response at 680 nm and nuclease digestion
control, (C) competition binding assay.
Fig. 3 G-tetrad selectivity analysis. (A) 50-tetrad versus 30-tetrad ligand
binding, (B) inverse G-tetrad selectivity between TmPyP4 and PhenDC3
with cKit1 (inset: [50Cy5_cKit1] = 0.5 nM).
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individual G-tetrad ends of the cKit1 structure. Such analyses
provide a higher degree of structural resolution to dissect the
molecular determinants of ligand binding at G-tetrads. More-
over, the unprecedented ability to rapidly and simply probe
G-tetrad specific binding events is expected to advance G4
ligand design toward higher selectivity and potentially novel
tetrad-specific pharmacological activity.
Ligand-induced fluorescence quenching of labelled G4-forming
oligonucleotides has been developed into a rapid and simple
equilibrium-binding assay. Cross-validation to literature values
describing ligand interactions with several important G4 structures
indicates that the present method produces accurate dissociation
constants. A key feature of this fluorescence quench assay is the
ability to distinguish K appD derived from defined G-tetrads, enabling
targeted structure–activity studies aimed at improving ligand
design and to probe tetrad-specific G4 topology. It was demon-
strated that G4 ligands exhibit strong and varied G-tetrad prefer-
ences for genomic G4 structures. This method facilitates a
rethinking of G4 ligand binding and selectivity: rather than being
simply sequence-specific (e.g. cKit1 vs. cMyc), G4 ligands bind to a
given G-quadruplex structure at distinct G-tetrads with differential
binding affinities.
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